AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32

Authors: Martin, JB Kasper, DL
Citation: Jb. Martin et Dl. Kasper, Conflict-of-interest policies, N ENG J MED, 344(13), 2001, pp. 1018-1018

Authors: Krinos, CM Coyne, MJ Weinacht, KG Tzianabos, AO Kasper, DL Comstock, LE
Citation: Cm. Krinos et al., Extensive surface diversity of a commensal microorganism by multiple DNA inversions, NATURE, 414(6863), 2001, pp. 555-558

Authors: Henneke, P Takeuchi, O van Strijp, JA Guttormsen, HK Smith, JA Schromm, AB Espevik, TA Akira, S Nizet, V Kasper, DL Golenbock, DT
Citation: P. Henneke et al., Novel engagement of CD14 and multiple toll-like receptors by group B streptococci, J IMMUNOL, 167(12), 2001, pp. 7069-7076

Authors: Cieslewicz, MJ Kasper, DL Wang, Y Wessels, MR
Citation: Mj. Cieslewicz et al., Functional analysis in type Ia group B Streptococcus of a cluster of genesinvolved in extracellular polysaccharide production by diverse species of streptococci, J BIOL CHEM, 276(1), 2001, pp. 139-146

Authors: Coyne, MJ Tzianabos, AO Mallory, BC Carey, VJ Kasper, DL Comstock, LE
Citation: Mj. Coyne et al., Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis, INFEC IMMUN, 69(7), 2001, pp. 4342-4350

Authors: Kalka-Moll, WM Wang, Y Comstock, LE Gonzalez, SE Tzianabos, AO Kasper, DL
Citation: Wm. Kalka-moll et al., Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain, INFEC IMMUN, 69(4), 2001, pp. 2339-2344

Authors: Paoletti, LC Rench, MA Kasper, DL Molrine, D Ambrosino, D Baker, CJ
Citation: Lc. Paoletti et al., Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B streptococcal type III conjugate vaccines, INFEC IMMUN, 69(11), 2001, pp. 6696-6701

Authors: Guttormsen, HK Kasper, DL
Citation: Hk. Guttormsen et Dl. Kasper, Bacterial vaccines, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 401-412

Authors: Martin, JB Kasper, DL
Citation: Jb. Martin et Dl. Kasper, In whose best interest? Breaching the academic-industrial wall, N ENG J MED, 343(22), 2000, pp. 1646-1649

Authors: Wang, Y Kalka-Moll, WM Roehrl, MH Kasper, DL
Citation: Y. Wang et al., Structural basis of the abscess-modulating polysaccharide A2 from Bacteroides fragilis, P NAS US, 97(25), 2000, pp. 13478-13483

Authors: Baker, CJ Paoletti, LC Rench, MA Guttormsen, HK Carey, VJ Hickman, ME Kasper, DL
Citation: Cj. Baker et al., Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women, J INFEC DIS, 182(4), 2000, pp. 1129-1138

Authors: Paoletti, LC Pinel, J Kennedy, RC Kasper, DL
Citation: Lc. Paoletti et al., Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate, J INFEC DIS, 181(2), 2000, pp. 653-658

Authors: Kalka-Moll, WM Tzianabos, AO Wang, Y Carey, VJ Finberg, RW Onderdonk, AB Kasper, DL
Citation: Wm. Kalka-moll et al., Effect of molecular size on the ability of zwitterionic polysaccharides tostimulate cellular immunity, J IMMUNOL, 164(2), 2000, pp. 719-724

Authors: Deng, LY Kasper, DL Krick, TP Wessels, MR
Citation: Ly. Deng et al., Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus, J BIOL CHEM, 275(11), 2000, pp. 7497-7504

Authors: Tzianabos, AO Finberg, RW Wang, Y Chan, M Onderdonk, AB Jennings, HJ Kasper, DL
Citation: Ao. Tzianabos et al., T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria, J BIOL CHEM, 275(10), 2000, pp. 6733-6740

Authors: Coyne, MJ Kalka-Moll, W Tzianabos, AO Kasper, DL Comstock, LE
Citation: Mj. Coyne et al., Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: Cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci, INFEC IMMUN, 68(11), 2000, pp. 6176-6181

Authors: Comstock, LE Pantosti, A Kasper, DL
Citation: Le. Comstock et al., Genetic diversity of the capsular polysaccharide C biosynthesis region of Bacteroides fragilis, INFEC IMMUN, 68(11), 2000, pp. 6182-6188

Authors: Paoletti, LC Madoff, LC Kasper, DL
Citation: Lc. Paoletti et al., Surface structures of group B streptococcus important in human immunity, GRAM-POSITIVE PATHOGENS, 2000, pp. 137-153

Authors: Paoletti, LC Pinel, J Johnson, KD Reinap, B Ross, RA Kasper, DL
Citation: Lc. Paoletti et al., Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII, J INFEC DIS, 180(3), 1999, pp. 892-895

Authors: Lachenauer, CS Kasper, DL Shimada, J Ichiman, Y Ohtsuka, H Kaku, M Paoletti, LC Ferrieri, P Madoff, LC
Citation: Cs. Lachenauer et al., Serotypes VI and VIII predominate among group B streptococci isolated frompregnant Japanese women, J INFEC DIS, 179(4), 1999, pp. 1030-1033

Authors: Baker, CJ Paoletti, LC Wessels, MR Guttormsen, HK Rench, MA Hickman, ME Kasper, DL
Citation: Cj. Baker et al., Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib, J INFEC DIS, 179(1), 1999, pp. 142-150

Authors: Tzianabos, AO Russell, PR Onderdonk, AB Gibson, FC Cywes, C Chan, M Finberg, RW Kasper, DL
Citation: Ao. Tzianabos et al., IL-2 mediates protection against abscess formation in an experimental model of sepsis, J IMMUNOL, 163(2), 1999, pp. 893-897

Authors: Brubaker, JO Li, Q Tzianabos, AO Kasper, DL Finberg, RW
Citation: Jo. Brubaker et al., Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis: Differential stimulatory effect on mouse and rat lymphocytes in vitro, J IMMUNOL, 162(4), 1999, pp. 2235-2242

Authors: Comstock, LE Coyne, MJ Tzianabos, AO Kasper, DL
Citation: Le. Comstock et al., Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: Characterization of the region from strain 638R, J BACT, 181(19), 1999, pp. 6192-6196

Authors: Kasper, DL Wessels, MR Guttormsen, HK Paoletti, LC Edwards, MS Baker, CJ
Citation: Dl. Kasper et al., Measurement of human antibodies to type III group B Streptococcus, INFEC IMMUN, 67(8), 1999, pp. 4303-4304
Risultati: 1-25 | 26-32